Some new insights into the effects of opioids in phasic and tonic nociceptive tests

Pain

Volumn 78, Issue 2, 1998, Pages 79-98

  McCormack, Keith ^a   Prather, Paul ^b   Chapleo, Chris ^c  

^a McCormack Limited   (United Kingdom)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Reckitt & Colman   (United Kingdom)

Author keywords

Fractional receptor occupancy; Neonate; Nociceptive tests; Opioids; Pertussis toxin

Indexed keywords

BUPRENORPHINE; FORMALDEHYDE; MORPHINE; OPIATE; PERTUSSIS TOXIN; SUFENTANIL;

ALLODYNIA; ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; ELECTROPHYSIOLOGY; HEATING; HOT PLATE TEST; HUMAN; HYPERALGESIA; LATENT PERIOD; MYELINATED NERVE; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; NONMYELINATED NERVE; PAIN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REVIEW; SENSORY NERVE; SYNAPSE; TAIL FLICK TEST;

EID: 0031771306     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00146-8     Document Type: Article

References (211)

1. Adachi T., Sato A., Sato Y., Schmidt R.F. Depending on the mode of application morphine enhances or depresses somatocardiac sympathetic A- and C-reflexes in anesthetized rats. Neurosci. Res. 15:1992;281-288.
2. Adriaensen H., Gybels J., Handwerker H.W.Q., van Hees J. Response properties of thin myelinated (A-γ) fibres in human skin nerves. J. Neurophysiol. 49:1983;111-122.
3. Andrews K., Fitzgerald M. The cutaneous withdrawal reflex in human neonates: sensitization, receptive fields, and the effects of contralateral stimulation. Pain. 56:1994;95-101.
4. Angulo y Gonzalez A.W. The prenatal development of behaviour in the albino rat. J. Comp. Neurol. 55:1932;395-442.
5. βγ. J. Biol. Chem. 271:1996;21309-21315.
6. Baba M., Oishi R., Saeki K. Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of μ opioid receptors in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;423-428.
7. Barrett D.A., Elias-Jones A.C., Rutter N., Shaw P.N., Davis S.S. Morphine kinetics after diamorphine infusion in premature neonates. Br. Clin. Pharmacol. 32:1991;31-37.
8. Barrett D.A., Simpson J., Rutter N., Kurihura-Bergstrom T., Shaw P.N., Davis S.S. The pharmacokinetic and physiological effects of buprenorphine infusion in premature neonates. Br. J. Pharmacol. 36:1993;215-219.
9. Beck P.W., Handwerker H.Q., Zimmermann M. Nervous outflow from the cat's foot during noxious radiant heat stimulation. Brain Res. 67:1974;373-386.
10. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
11. Bennett G.J. An animal model of neuropathic pain: a review. Muscle Nerve. 16:1993;1040-1048.
12. Berhow M.T., Hiroi N., Nestler E.J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16:1996;4707-4715.
13. Berzetei-Gurske I.P., White A., Polgar W., DeCosta B.R., Pasternak G.W., Toll L. The in vitro pharmacological characterization of naloxone benzoylhydrazone. Eur. J. Pharmacol. 277:1995;257-263.
14. Besse D., Lombard M.C., Zajac J.M., Roques B.P., Besson J.M. Pre- and postsynaptic location of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord. Prog. Clin. Biol. Res. 328:1990;183-186.
15. Besson J.-M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67:1987;67-186.
16. Bhatt-Mehta V., Rosen D.A. Management of acute pain in children. Clin. Pharm. 10:1991;667-685.
17. Bicknell H.R. Jr., Beal J.A. Axonal and dendritic development of substantia gelatinosa neurons in the lumbosacral spinal cord of the rat. J. Comp. Neurol. 226:1984;508-522.
18. Bing Z., Villanueva L., Le Bars D. Effects of systematic morphine upon A delta- and C-fibre evoked activities of subnucleus reticularis dorsalis neurones in the rat medulla. Eur. J. Pharmacol. 164:1989;85-92.
19. Bouhassira D., Villaneuva L., Le Bars D. Intracerebroventricular morphine decreases descending inhibitions acting on lumbar dorsal horn neuronal activities related to pain in the rat. J. Pharmacol. Exp. Ther. 247:1988;332-342.
20. Bouhassira D., Bing Z., Le Bars D. Studies of brain structures involved in diffuse noxious inhibitory controls in the rat: the rostral ventromedial medulla. J. Physiol.(Lond.). 463:1993;667-687.
21. Brown A.G., Rose P.K., Snow P.J. Morphology of hair follicle afferent fibre collaterals in the cat spinal cord. J. Physiol. (Lond.). 272:1977;770-797.
22. Cahusac P.M., Evans R.H., Hill R.G., Rodriquez R.E., Smith D.A. The behavioural effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology. 23:1984;719-724.
23. Campbell J.N., Raja S.N., Meyer R.A., McKinnon S.E. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain. 32:1988;89-94.
24. Carroll J.A., Shaw J.S., Wickenden A.D. The physiological relevance of low agonist affinity binding at opioid mu receptors. Br. J. Pharmacol. 94:1988;625-631.
25. Carstens E., Tulloch I., Zieglgansberger W., Zimmermann M. Presynaptic excitability changes induced by morphine in single cutaneous afferent C-and A-fibres. Pflügers Arch. Eur. J. Physiol. 379:1979;143-147.
26. Castro-Lopes J.M., Tavares I., Coimbra A. GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res. 620:1993;287-294.
27. Chakour M.C., Gibson S.J., Bradbeer M., Helme R.D. The effect of age on A delta- and C-fibre thermal pain perception. Pain. 64:1996;143-152.
28. Chay P.C., Duffy B.J., Walker J.S. Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin. Pharmacol. Ther. 51:1992;334-342.
29. Cheng J., Roques B.P., Gacel G.A., Huang E., Pasternak G.W. Kappa 3 opiate receptor binding in the mouse and rat. Eur. J. Pharmacol. 226:1992;15-20.
30. Cheng J., Standifer K.M., Tublin P.R., Su W., Pasternak G.W. Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J. Neurochem. 65:1995;170-175.
31. Childers S.R. Opioid receptors: pinniing down the opiate targets. Curr. Biol. 7:1997;R695-R697.
32. Childers S.R. Opiate inhibited adenylate cyclase in rat brain membranes depletedof Gs-stimulated adenylate cyclase. J. Neeurochem. 50:1988;543-553.
33. Childers S.R., Fleming L.M., Selley D.E., McNutt R.W., Chang K.J. BW373U86: a non-peptidic delta-opioid agonist with novel receptor-G-protein-mediated actions in the rat brain membranes and neuroblastoma cells. Mol. Pharmacol. 44:1993;827-834.
34. Choonara I.A., McKay P., Hain R., Rane A. Morphine metabolism in children. Br. J. Clin. Pharmacol. 28:1989;599-604.
35. Chong M.S., Fitzgerald M., Winter J., Hu-Tsai M., Emson P.C., Wiese U., Woolfe C.J. GAP-43 mRNA in rat spinal cord and dorsal root neurons: developmental changes and re-expression following peripheral nerve injury. Eur. J. Neurosci. 4:1992;883-895.
36. Coggeshall R.E., Jennings E.A., Fitzgerald M. Evidence that large myelinated primary afferent fibers make synaptic contacts in lamina II of neonatal rats. Dev. Brain Res. 92:1996;81-90.
37. Devor, M. and Wall, P.D., Plasticity in the spinal cord sensory map following peripheral nerve injury in rats, J. Neurosci., 1 (1981a) 679-684.
38. Devor, M. and Wall, P.D., Effect of peripheral nerve injury on receptive fields of cells in the cat spinal cord, J. Comp. Neurol., 199 (1981b) 277-291.
39. Dickenson A.H., Le Bars D., Besson J.-M. Diffuse noxious inhibitory controls (DNIC). Effects on trigeminal nucleus caudalic neurones in the rat. Brain Res. 200:1980;293-305.
40. Dickenson A.H., Rivot J.P., Chaouch A., Besson J.-M., Le Bars D. Diffuse noxious inhibitory controls (DNIC) in the rat with or without pCPA treatment. Brain Res. 216:1981;313-321.
41. Dickenson A.H., Le Bars D. Lack of evidence for increased descending inhibition on the dorsal horn of the rat following periaqueductal grey morphine microinjections. Br. J. Pharmacol. 9:1987;271-280.
42. Dickenson A.H., Sullivan A.F., McQuay H.J. Intrathecal etorphine fentanyl and buprenorphine on spinal nociceptive neurones in the rat. Pain. 42:1990;227-234.
43. Dirig D.M., Yaksh R.L. Differential right shifts in the dose-response curve for intrathecal morphine and sufentanil as a function of stimulus intensity. Pain. 62:1995;321-328.
44. Doi T., Jurna I. Analgesic effect of intrathecal morphine demonstrated in ascending nociceptive activity in the rat spinal cord and ineffectiveness of caerulein and cholecystokinin octapeptide. Brain Res. 234:1982;399-407.
45. Draisci G., Kajander K.C., Dubner R., Bennett G.J., Iadorola M.J. Up-regulation of opioid gene expression in the spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 560:1991;186-192.
46. Dubner, R., Price, D.D., Beitel, R.E. and Hu, J.W., Peripheral neural correlates of behaviour in monkey and human related to sensory discriminative aspects of pain. In: D.J. Anderson and B. Matthews (Eds.), Pain in the Trigeminal Region, Elsevier, New York, 1977, pp. 57-66.
47. Dubner, R., Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. In: M.R. Bond, J.E. Charlton and C.J. Woolf (Eds.). Proceedings of the Sixth World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 263-276.
48. Ekholm J. Postnatal changes in cutaneous reflexes and in the discharge pattern of cutaneous and articular sense organs. A morphological and physiological study in the cat. Acta Physiol. Scand. 297(Suppl.):1967;1-130.
49. Fields T.A., Casey P.J. Phosphorylation of Gz alpha by protein kinase C blocks interaction with the beta gamma complex. J. Biol. Chem. 270:1995;23119-23125.
50. Fields T.A., Casey P.J. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J. 32:1997;561-571.
51. Fitzgerald M., Gibson S. The postnatal physiological and neurochemical development of peripheral sensory C fibres. Neuroscience. 13:1984;933-944.
52. Fitzgerald M. The post-natal development of cutaneous afferent fibre input and receptive field organization in the rat dorsal horn. J. Physiol. (Lond.). 364:1985;1-18.
53. Fitzgerald, M., Functional plasticity in the somatosensory system. In: W. Winlow and C.R. McCrohan (Eds.), Growth and plasticity of neural connections, Manchester University Press, Manchester, 1987, pp. 165-185.
54. Fitzgerald M. The development of activity evoked by fine diameter cutaneous fibres in the spinal cord of the newborn rat. Neurosci. Lett. 86:1988;161-166.
55. Fitzgerald, M., The course and termination of primary afferent fibres. In: P.D. Wall (Ed.), Textbook of Pain, P.D., Churchill Livingstone, Edinburgh, 1989, pp. 46-62.
56. Fitzgerald M., Butcher T., Shortland P. Developmental changes in the laminar termination of A fibre cutaneous sensory afferents in the rat spina1 cord dorsal horn. J. Comp. Neurol. 348:1994;225-233.
57. Fitzgerald M. Developmental biology of inflammatory pain. Br. J. Anaesth. 75:1995;177-185.
58. Frost J.J., Wagner H.N. Jr. Kinetics of binding to opioid receptors in vivo predicted from in vitro parameters. Brain Res. 305:1984;1-11.
59. Fukuda K., Kato S., Morikawa H., Shoda T., Mori K. Functional coupling of the delta-, mu- and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 67:1996;1309-1316.
60. Furchgott R.F. The pharmacology of vascular smooth muscle. Pharmacol. Rev. 7:1955;183-265.
61. Garcia-Arraras J.E., Murakoshi T., Yanagisawa M., Otsuka M. Descending inhibition of slow spinal reflex in an in vitro preparation of the newborn rat and its possible involvement in pain control. Brain Res. 379:1986;188-191.
62. Gibbs O.S., Bobb A. The toxicity of morphine on the new born rat. J. Pharmacol. Exp. Ther. 63:1938;10.
63. Goettl V.M., Larson A.A. Antinociception induced by 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX. Brain Res. 642:1994;334-338.
64. Guirimand F., Chauvin M., Willer J.C., Le Bars D. Buprenorphine blocks diffuse noxious inhibitory controls in the rat. Eur. J. Pharmacol. 294:1995;651-659.
65. Guy E.R., Abbott F.V. The behavioral response to formalin in preweanling rats. Pain. 51:1992;81-90.
66. Heerding J., Raynor H., Kong L.Y., Reisine T. Mutagenesis reveals that agonists and peptide antagonists bind in fundamentally distinct manners to the rat mu receptor than do non-peptide antagonists. Regul. Pept. 54:1994;119-120.
67. Herdegen T., Kovary K., Leah J.D., Bravo R. Specific temporal and spatial distribution of jun, Fos and Krox-24 proteins in spinal neurons following noxious trans-synaptic stimulation. J. Comp. Neurol. 313:1991;178-191.
68. Hylden J.L., Nahin R.L., Dubner R. Altered responses of nociceptive cat lamina I spinal dorsal horn neurons after chronic sciatic neuroma formation. Brain Res. 411:1987;341-350.
69. Jennings E., Fitzgerald M. C-fos can be induced in the neonatal rat spinal cord by both noxious and innocuous peripheral stimulation. Pain. 68:1996;301-306.
70. Jett M.F., McGuirk J., Walligora D., Hunter J.C. The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain. 69:1997;161-169.
71. Jiang Q., Mosberg H.I., Porreca F. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther. 254:1990;683-689.
72. Jurna I., Heinz G. Differential effects of morphine and opioid analgesics on A and C fibre-evoked activity in ascending axons of the rat spinal cord. Brain Res. 171:1979;573-576.
73. Jurna I. Effect of stimulation in the periaqueductal grey matter on activity in ascending axons of the rat spinal cord: selective inhibition of activity evoked by afferent A delta and C fibre stimulation and failure of naloxone to reduce inhibition. Brain Res. 196:1980;33-42.
74. Kajander K.C., Sahara Y., Iadarola M.J., Bennett G.J. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides. 11:1990;719-728.
75. 2 laser stimulation. J. Neurol. Sci. 125:1994;198-205.
76. Kellstein D.E., Price D.D., Hayes R.L., Mayer D.J. Evidence that substance P selectively modulates C-fiber-evoked discharge of dorsal horn nociceptive neurons. Brain Res. 526:1990;291-298.
77. Kessler W., Kiechhoff C., Reeh P.W., Handwerker H.O. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp. Brain Res. 91:1992;467-476.
78. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
79. Kong H., Raynor K., Yasuda K., Moe S.T., Portoghese P.S., Bell G.I., Reisine T. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268:1993;23055-23058.
80. Koren G., Butt W., Chinyanga H., Soldin S., Tan Y.K., Pape K. Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety. J. Pediatr. 107:1985;963-967.
81. Kozasa T., Gilman A.G. Protein kinase C phosphorylates G12 alpha and inhibits its interaction with G beta gamma. J. Biol. Chem. 271:1996;12562-12567.
82. Kristensen J.D., Karlsten R., Gordh T., Berge O.G. The NMDA antagnost 3-(2-carboxypiperazin-4-yl) propyl-1-phoshonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat. Pain. 56:1994;59-67.
83. Kupferberg H.J., Way E.L. Pharmacologic basis for the increased sensitivity of the newborn rat to morphine. J. Pharmacol. Exp. Ther. 14:1963;105-112.
84. B receptors in the neonatal rat spinal cord in vitro. Brain Res. 717:1996;76-80.
85. Laird J.M., Bennett G.J. Dorsal root potentials and afferent input to the spinal cord in rats with an experimental peripheral neuropathy. Brain Res. 584:1992;181-190.
86. Lawson S.J., Davies H.J., Bennett J.P., Lowrie M.B. Evidence that spinal interneurons undergo programmed cell death postnatally in the rat. Eur. J. Neurosci. 9:1997;794-799.
87. Le Bars D., Guilbaud G., Jurna I., Besson J.M. Differential effects of morphine on responses of dorsal horn lamina V type cells elicited by A and C fibre stimulation in the spinal cat. Brain Res. 22:1976;518-524.
88. Le Bars D., Dickenson A.H., Besson J.-M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain. 6:1979;283-304.
89. Le Bars D., Chitour D., Kraus E., Clot A.M., Dickenson A.H., Besson J.-M. The effect of systemic morphine upon diffuse noxious inhibitory controls (DNIC) in the rat: evidence for a lifting of certain descending inhibitory controls of dorsal horn convergent neurones. Brain Res. 215:1981;257-274.
90. Le Bars D., Villanueva L., Bouhassira D., Willer J.C. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol. Fizio Eksp. Ter. 4:1992;55-65.
91. Leem J.W., Willis W.D., Chung J.M. Cutaneous sensory receptors in the rat foot. Neurophysiology. 69:1993;1684-1699.
92. Li L.Y., Chang K.J. The stimulatory effect of opioids on mitogen-activated protein in kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol. 50:1996;599-602.
93. Light, A.R. and Perl, E.R., Re-examination of the dorsal root projection to the spinal dorsal horn including observations on the differential termination of coarse and fine fibers, J. Comp. Neurol., 186 (1979a) 117-131.
94. Light, A.R. and Perl, E.R., Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers, J. Comp. Neurol., 186 (1979b) 133-150.
95. Lu, Y., Pirec, V. and Yeomans, D.C., Differential antinociceptive effects of spinal opioids on foot withdrawal responses evoked by C fibre and A delta nociceptor activation, Br. J. Pharmacol., 121 (1997) in press.
96. Lufty K., Cai S.X., Woodward R.M., Weber E. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice. Pain. 70:1997;31-40.
97. Luke M.C., Hahn E.F., Price M., Pasternak G.W. Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci. 43:1988;1249-1256.
98. Lynn B., Carpenter S.E. Primary afferent units from the hairy skin of the rat hind limb. Brain Res. 238:1982;29-43.
99. Lynn A.M., Slattery J.T. Morphine pharmacokinetics in early infancy. Anesthesiology. 66:1987;136-139.
100. Ma Q.P., Woolf C.J. Basal and touch-evoked fos-like immunoreactivity during experimental inflammation in the rat. Pain. 6:1996;307-316.
101. McCormack, K., Brune, K., Budd, K. and Prather, P., Experimental indices used to classify opioids as partial or full receptor agonists may have limited clinical utility. In: 8th World Congress on Pain, Abstract No. 88, IASP Press, Seattle, 1996, pp. 464.
102. McLaughlin, C.R. and Dewey, W.L., A comparison of the antinociceptive effects of opioid in neonatal and adult rats. In: L. Harri (Ed.), Problems of Drug Dependence 1991. Proceedings of the 53rd Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc. Research Monograph 119, US Department of Health and Human Services, Rockville, USA, 1992, pp. 273.
103. McLaughlin C.R., Dewey W.L. A comparison of the antinociceptive effects of opioid agonists in neonatal and adult rats in phasic and tonic nociceptive tests. Pharmacol. Biochem. Behav. 49:1994;1017-1023.
104. McLaughlin C.R., Tao Q., Abood M.E. Analysis of the antinociceptive actions of the μ-opioid agonist enadoline (CI-977) in neonatal and adult rats: comparison to μ-opioid receptor mRNA ontogen. Drug Alcohol Depend. 38:1995;261-269.
105. McQuay, H.J., Moore, R.A. and Bullingham, R.E.S., Buprenorphine kinetics. In: K.M. Foley and C.E. Inturrisi (Eds.), Advances in Pain Research and Therapy, Vol. 8, Raven Press, New York, 1986.
106. McQuay H.J., Sullivan A.F., Smallman K., Dickerson A.H. Intrathecal opioids, potency and lipophilicity. Pain. 36:1989;111-115.
107. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., Moore R.A. A systematic review of anti-depressants in neuropathic pain. Pain. 68:1996;217-227.
108. McRorie T.I., Lynn A.M., Nespeca M.K., Opheim K.E., Slattery J.T. The maturation of morphine clearance and metabolism. Am. J. Dis. Child. 146:1992;972-976.
109. Melzack R. Sensory and pharmacological modulation of pain. Can. J. Physiol. Pharmacol. 69:1991;695-696.
110. Miyata Y., Nakano S., Yasuda H. Postnatal transient expression of long-lasting descending inhibitory effect on spinal reflexes in the rat. Neurosci. Res. 4:1987;268-278.
111. Molander C., Hongpaisan J., Grant G. Changing pattern of c-Fos expression in spinal cord neurons after electrical stimulation of the chronically injured sciatic nerve in the rat. Neuroscience. 50:1992;223-226.
112. Morton C.R., Maisch B., Zimmermann M. Diffuse noxious inhibitory controls of lumbar spinal neurons involve a supraspinal loop in the cat. Brain Res. 410:1987;347-352.
113. Morton C.R., Du H.J., Xiao H.M., Maisch B., Zimmermann M. Inhibition of nociceptive responses of lumbar dorsal horn neurones by remote noxious afferent stimulation in the cat. Pain. 34:1988;75-83.
114. Murray C.W., Cowan A., Larson A.A. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain. 44:1991;179-185.
115. Narayanan C.H., Fox M.W., Hamburger W. Prenatal development of spontaneous and evoked activity in the rat (Rattus norvegicus albinus). Behaviour. 40:1971;100-134.
116. Näsström J.B., Schneider S.P., Perl E.R. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur. J. Pharmacol. 212:1992;2l-29.
117. Nestler E.J. Cellular responses to chronic treatment with drugs of abuse. Crit. Rev. Neurobiol. 7:1993;23-29.
118. Nickerson M. Receptor occupancy and tissue response. Nature. 178:1956;697-698.
119. Niv D., Whitwam J.G. Selective effect of fentanyl on group III and IV somatosympathetic reflexes. Neuropharmacology. 22:1983;703-709.
120. Noel F., Iourgenko V., Pouille Y., Hanoune J. Recent advances in the molecular effects of opiates. Med. Sci. 10:1994;1116-1126.
121. Ochoa, J. and Mair, W.G., The normal sural nerve in man. I. Ultrastructure and numbers of fibres and cells, Acta Neuropathol. (Berl.), 13 (1969a) 197-216.
122. Ochoa, J. and Mair, W.G., The normal sural nerve in man. II. Changes in the axons and Schwann cells due to ageing, Acta Neuropathol. (Berl.), 13 (1969b) 217-239.
123. Odensjo-Swenzon G., Chakrabarti M., Sapsed Byrne S., Whitwam J.G. Selective effect of sufentanil on group III (A delta) and group IV (C) somatosympathetic reflexes. Acta Anaesthesiol. Scand. 30:1986;545-548.
124. Olkkola K.T., Maunuksela E.-L., Korpela R. Pharmacokinetics of intravenous buprenorphine in children. Br. J. Clin. Pharmacol. 28:1989;202-204.
125. Ortiz J., Harris H.W., Guitart X., Terwilliger R.Z., Haycock J.W., Nestler E.J. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J. Neurosci. 15:1995;1285-1297.
126. Osugi T., Ikemoto M., Tanaka H., Wang X.B., Miki N. Modulation by chronic morphine administration of single-stranded cAMP response element (ssCRE) binding proteins in the mouse cerebellum. Brain Res. Mol. Brain Res. 21:1994;256-262.
127. Paul D., Levison J.A., Howard D.H., Pick C.G., Hahn E.F., Pasternak G.W. Naloxone benzoylhydrazone (NalBzoH) analgesia. J. Pharmacol. Exp. Ther. 255:1990;769-774.
128. Paul D., Pick C.G., Tive L.A., Pasternak G.W. Pharmacological characterization of nalorphine, a kappa 3 analgesic. J. Pharmacol. Exp. Ther. 257:1991;1-7.
129. Pick C.G., Peter Y., Schreiber S., Weizman R. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia. Brain Res. 744:1997;41-46.
130. Price D.D., Hu J.W., Dubner R., Gracely R.H. Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain. 3:1977;57-68.
131. 3H) naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate. Mol. Pharmacol. 36:1989;67-74.
132. Price D.D. Selective activation of A-delta and C nociceptive afferents by different parameters of nociceptive heat stimulation: a tool for analysis of central mechanisms of pain. Pain. 68:1996;1-3.
133. Puig S., Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 64:1996;345-355.
134. Raffa R.B., Martinez R.P., Connelly C.D. G-protein antisense oligodeoxynucleotides and mu-opioid supraspinal antinociception. Eur. J. Pharmacol. 258:1994;R5-R7.
135. Raffa R.B., Connelly C.D., Chambers J.R., Stone D.J. Alpha-subunit G-protein antisense oligodeoxynucleotide effects on supraspinal (i.c.v.) alpha-2-adrenoceptor antinociception in mice. Life Sci. 58:1996;77-80.
136. Raigorodsky G., Urca G. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate. Eur. J. Pharmacol. 182:1990;137-147.
137. Ralston H.J., Ralston D.D. The distribution of dorsal root axons in laminae I, II and III of the macaque spinal cord: a quantitative electron microscope study. J. Comp. Neurol. 184:1979;643-684.
138. Reichling D.B., Kyrozis A., Wang J., MacDermott A.B. Mechanisms of GABA and glycine depolarization-induced calcium transients in rat dorsal horn neurons. J. Physiol. 476:1994;411-421.
139. Rosenbaum J.S., Holford N.H.G., Sadée W. In vivo receptor binding of opioid drugs at the mu site. J. Pharmacol. Exp. Ther. 233:1985;735-740.
140. Sadée W., Rosenbaum J.S., Herz A. Buprenorphine: differential interaction with opiate receptor subtypes in vivo. J. Pharmacol. Exp. Ther. 223:1982;157-162.
141. Schreiber, S., Backer, M.M., Yanai, J. and Pick, C.G., The antinociceptive effect of fluvoxamine, Eur. Neuropsychopharmacol., (1996a) 281-284.
142. Schreiber, S., Backer, M.M., Weizman, R. and Pick, C.G., The antinociceptive effects of fluoexitine, Pain Clin., 9 (1996b) 349-356.
143. Seltzer Z., Beilin B.Z., Ginzburg R., Paran Y., Shimko T. The role of injury discharge in the induction of neuropathic pain behaviour in rats. Pain. 46:1991;327-336.
144. Shah S., Duttaroy A., Davis T., Yoburn B.C. Spinal and supraspinal effects of pertussis toxin on opioid analgesia. Pharmacol. Biochem. Behav. 49:1994;773-776.
145. Shortland P., Woolf C.J., Fitzgerald M. Morphology and somatotropic organization of the central terminals of hindlimb hair follicle afferents in the rat lumbar spinal cord. J. Comp. Neurol. 289:1989;416-433.
146. Shortland, P. and Woolf, C.J., Chronic peripheral nerve section results in a rearrangement of the central axonal arborizations of axotomized A beta primary afferent neurons in the rat spinal cord, J. Comp. Neurol., 330 (1993a) 65-82.
147. Shortland, P. and Woolf, C.J., Morphology and somatotopy of the central arborizations of rapidly adapting glabrous skin afferents in the rat lumber spinal cord, J. Comp. Neurol., 329 (1993b) 491-511.
148. Simpson J.N., McGinty J.F. Forskolin increases phosphorylated CREB and fos immunoreactivity in rat striatum. NeuroReport. 5:1994;1213-1216.
149. Simpson J.N., McGinty J.F. Forskolin induces preproenkepephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry. Synapse. 19:1995;151-159.
150. Sivilotti L.G., Thompson S.W., Woolf C.J. Rate of rise of the cumulative depolarization evoked by repetitive stimulation of small-caliber afferents is a predictor of action potential windup in rat spinal neurons in vitro. J. Neurophysiol. 69:1993;1621-1631.
151. Sorkin L.S., Puig S. Neuronal model of tactile allodynia produced by spinal strychnine: effects of excitatory amino acid receptor antagonists and a mu opiate receptor agonist. Pain. 68:1996;283-292.
152. Sotgiu M.L., Biella G., Riva L. Poststimulus afterdischarges of spinal WDR and NS units in rats with chronic nerve constriction. NeuroReport. 6:1995;1021-1024.
153. Standifer K.M., Rossi G.C., Pasternak G.W. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol. Pharmacol. 50:1996;293-298.
154. Stanski D.R., Paalzow L., Edlund P.O. Morphine pharmacokinetics: GLC essay versus radio immunoassay. J. Pharm. Sci. 71:1982;314-317.
155. Steen, K.H. and Reeh, P.W., Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro, J. Neurophysiol., 70 (1993a) 397-405.
156. Steen, K.H. and Reeh, P.W., Sustained graded pain and hyperalgesia from harmless experimental tissue acidosis in human skin, Neurosci. Lett., 154 (1993b) 113-116.
157. Stelzner D.J. The normal postnatal development of synaptic end-feet in the lumbosacral spinal cord and of responses in the hind limbs of the albino rat. Exp. Neurol. 31:1971;337-357.
158. Stephenson R.P. A modification of receptor theory. Br. J. Pharmacol. 11:1956;379-393.
159. Strittmatter S.M., Cannon S.C., Ross E.M., Higashijima T., Fishman M.C. GAP-43 augments G protein-coupled receptor transduction in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. USA. 90:1993;5327-5331.
160. Sugiura Y., Lee C.L., Perl E.R. Central projections of identified, unmyelinated (C) afferent fibres innervating mammalian skin. Science. 234:1986;358-361.
161. Swenzon G.O., Chakrabarti M.K., Sapsed-Byrne S., Whitwam J.G. Selective depression by alfentanil of group III and IV somatosympathetic reflexes in the dog. Br. J. Anaesth. 61:1988;441-445.
162. Szücs M., Coscia C.J. Evidence for δ-opioid binding and GTP-regulatory proteins in 5-day-old rat brain membranes. J. Neurochem. 54:1990;1419-1425.
163. Tarasiuk A., Gibbs L., Kendig J.J. Descending inhibition in neonatal rat spinal cord: actions of pentobarbital and morphine. Brain Res. Bull. 41:1996;39-45.
164. Thomas J.M., Hoffman B.B. Buprenorphine prevents and reverses the expression of chronic etorphine-induced sensitization of adenylyl cyclase in SK-N-SH human neuroblastoma cells. J. Pharmacol. Exp. Ther. 264:1993;368-374.
165. Thompson W.J., Anderson P.S., Britcher S.F., Lyle T.A., Thies J.E., Magill C.A., Varga S.L., Schwering J.E., Lyle P.A., Christy M.E.et al. Synthesis and pharmacological evaluation of a series of dibenzo (a,d) cycloalkenimines as N-methyl-D-aspartate antagonists. J. Med. Chem. 33:1990;789-808.
166. Thorn S.A., Herrero J.F., Headley P.M. Stimulus intensity and the comparative efficacy of mu- and kappa- opioid agonists on nociceptive spinal reflexes in the rat. Brain Res. 663:1994;352-356.
167. Toll L. Comparison of binding affinities and adenylate cyclase inhibition for the determination of efficacy at mu-opioid receptors in a neuroblastoma cell line NIDA Res. Monogr. Ser. 105:1991;520-521.
168. Toll L. Comparison of mu opioid receptor binding an intact neuroblastoma cells with guinea pig brain and neuroblastoma cell membranes. J. Pharmacol. Exp. Ther. 260:1992;9-15.
169. Toll L. Intact cell binding and the relation to opioid activities in SH-Sy5Y cells. J. Pharmacol. Exp. Ther. 273:1995;721-727.
170. Torebjörk H.E., Hallin R.G. Perceptual changes accompanying controlled preferential blocking of A and C fibre responses in intact human skin nerves. Exp. Brain Res. 16:1973;321-332.
171. Torebjörk H.E., Ochoa J.L. Specific sensations evoked by activity in single identified sensory units in man. Acta Physiol. Scand. 110:1980;445-447.
172. Ui, M., Pertussis toxin as a valuable probe for G-protein involvement in signal transduction. In: J. Moss and M. Vaughan (Eds.), ADP-ribosylating toxins and G proteins: insights into signal transduction, American Society for Microbiology, Washington, WA, 1990, pp. 45-78.
173. van Gelderen J.G., Daeffler L., Scherrer D., Mousli M., Landry Y., Giles J.P. M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity? J. Recept. Signal Transduct. Res. 16:1996;135-148.
174. Villiger J.W. Binding of buprenorphine to opioid receptors. Regulation by guanyl nucleotides and metal ions. Neuropharmacology. 260:1984;373-375.
175. Wallis D.I., Wu J., Wang X.C. Is 5-hydroxytryptamine mediating descending inhibition in the neonatal rat spinal cord through different receptor subtypes? Eur. J. Pharmacol. 250:1993;371-377.
176. Walters T.J., Sweeney H.L., Farrar R.P. Influence of electrical stimulation on a fast-twitch muscle in aging rats. J. Appl. Physiol. 7:1991;1921-1928.
177. Wang, C., Chakrabarti, D.C., Galletly, D.C. and Whitwam, J.G., Relative effects of intrathecal administration of fentanyl and midazolam on A-delta and C fibre reflexes, Neuropharmacol., 3l (1992a) 439-444.
178. Wang, C., Chakrabarti, M.K. and Whitwam, J.G., Effect of low and high concentration of alfentanil administered intrathecally on A delta and C fibre mediated somatosympathetic reflexes, Br. J. Anaesth., 68, (1992b) 503-507.
179. Wang, C., Chakrabarti, M.K. and Whitwam, J.G., Lack of a ceiling effect for intrathecal buprenorphine in C fibre mediated somatosympathetic reflexes, Br. J. Anaesth., 71 (1993a) 528-533.
180. Wang, C., Koutsoukou-Dritsopoulou, A., Chakrabarti, M.K., Holdcfroft, A. and Whitwam, J.G., Differential effects of altentanil, fentanyl, pethidine and lignocaine administered intrathecally on nociceptive response evoked by low and high frequency stimulation of somatic nerves, Br. J. Anaesth., 70 (1993b) 63-69.
181. Wang, C., Chakrabarti, M.K. and Whitwam, J.G., Effect of ICI197067, kappa-opioid receptor agonist, spinally on A delta and C reflexes and intracerebrally on respiration, Eur. J. Pharmacol, 243 (1993c) 113-121.
182. Way W.L., Costley E.C., Way E.L. Respiratory sensitivity of the newborn infant to maperidine and morphine. Clin. Pharmacol. Ther. 6:1965;454-461.
183. Wheeler-Aceto H., Cowan A. Buprenorphine and morphine cause antinociception by different transduction mechanisms. Eur. J. Pharmacol. 195:1991;411-413.
184. Wheeler-Aceto, H. and Cowan, A., Effect of pertussis toxin (PTX) or the antinociceptive profile of buprenorphine (B) and morphine (M): evidence for differential regulation of pain transmission. In: L. Harris (Ed.), Problems of Drug Dependence 1991. Proceedings of the 53rd Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc., Research Monograph 119, NIDR, Rockville, USA, 1992, pp. 309.
185. Widnell K.L., Russell D.S., Nestler E.J. Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc. Natl. Acad. Sci. USA. 94:1994;10947-10951.
186. Widnell K.L., Self D.W., Lane S.B., Russell D.S., Vaidya V.A., Miserendino M.J., Rubin C.S., Duman D.S., Nestler E.J. Regulation of CREB expression: in vitro evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276:1996;306-315.
187. Weisenfeld-Hallin Z. The effects of intrathecal morphine and naltrexone on autonomy in sciatic nerve sectioned rats. Pain. 18:1984;267-278.
188. Wilcox G.L., Carlsson K.H., Jochim A., Jurna I. Mutual potentiation of antinociceptive effects of morphine and clonideine on motor and sensory responses in rat spinal cord. Brain Res. 405:1987;84-93.
189. Williams S., Evan G., Hunt S.P. Spinal c-fos induction by sensory stimulation in neonatal rats. Neurosci. Lett. 109:1990;309-314.
190. Windh R.T., Kuhn C.M. Increased sensitivity to Mu opiate antinociception in the neonatal rat despite weaker receptor-guanyl nucleotide binding protein coupling. J. Pharmacol. Exp. Ther. 273:1995;1353-1360.
191. Windh R.T., Little P.J., Kuhn C.M. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies. J. Pharmacol. Exp. Ther. 273:1995;1361-1374.
192. Womer D.E., De Lapp N.W., Shannon H.E. Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice. Pain. 70:1997;223-228.
193. Wong, C.S., Su, Y.F., Chang, K.J. and Watkins, W.D., Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high-affinity state of opioid receptors, Anesthesiology, 77 (1992a) 691-699.
194. Wong, C.S., Su, Y.F., Watkins, W.D. and Chang, K.J., Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes, J. Pharmacol. Exp. Ther., 262 (1992b) 317-326.
195. Wong C.S., Su Y.F., Watkins W.D., Chang K.-J. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5′-yl imidodiphosphate. J. Pharmacol. Exp. Ther. 268:1994;653-661.
196. Woodward R.M., Huettner J.E., Guastella J., Keana J.F., Weber E. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high afffinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol. 47:1995;568-581.
197. Woolf C.J., Wall P.D. Chronic peripheral nerve section diminishes the primary afferent A-fibre mediated inhibition of rat dorsal horn neurones. Brain Res. 242:1982;77-85.
198. Woolf, C.J. and Wall, P.D., Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat, J. Neurosci., 6 (1986a) 1433-1442.
199. Woolf, C.J. and Wall, P.D., Morphine-sensitive and morphine-insensitive actions of C-fibre input on the rat spinal cord, Neurosci. Lett., 64 (1986b) 221-225.
200. Woolf C.J., Thompson S.W.N., King A.E. Prolonged primer, afferent induced alterations in dorsal horn neurones, an intracellular analysis in vivo and in vitro. J. Physiol. 83:1989;255-266.
201. Woolf C.J. Generation of acute pain: central mechanisms. Br. Med. Bull. 47:1991;523-533.
202. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
203. Woolf C.J., Shortland P., Coggeshall R.E. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature. 355:1992;75-79.
204. Woolf C.J., Doubell T.P. The pathophysiology of chronic pain, increased sensitivity to low threshold A beta-fibre inputs. Curr. Opin. Neurobiol. 4:1994;525-534.
205. Yabaluri N., Medzihradsky F. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate. Mol. Pharmacol. 48:1995;690-695.
206. Yeomans D.C., Proudfit H.K. Characterization of the foot withdrawal response to noxious radiant heat in the rat. Pain. 59:1994;85-94.
207. Yeomans D.C., Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain. 68:1996;141-150.
208. Yeomans, D.C., Pirec, V. and Proudfit, H.K., Nociceptive responses to high and low rates of noxious cutanous heating are mediated by different nociceptors in the rat: behavioural evidence, Pain, 68 (1996a) 133-140.
209. Yeomans, D.C., Cooper, B.Y. and Vierck, C.J., Jr., Effects of systemic morphine on responses of primates to first or second pain sensations, Pain, 66 (1996b) 253-263.
210. Yi D.K., Barr G.A. The induction of Fos-like immunoreactivity by noxious thermal, mechanical and chemical stimuli in the lumbar spinal cord of infant rats. Pain. 60:1995;257-265.
211. Yuge O., Kitahata L.M., Collins J.G. sumot, Matsumoto M., Tabatabai M., Suzukawa M., Tanaka A. Fentanyl and alfentanil suppress brainstem pain transmission. Anesth. Analgr. 64:1985;597-600.